Research Institute

FibroScan®

 

SYMPTOMS

Are you worried about your liver health? HRI has dedicated technicians that pre-screen and identify potential Non-Alcoholic Steatohepatis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD). NASH and NAFLD have emerged as the most common chronic liver diseases worldwide, affecting up to 30% of adults in developed countries. Our goal is to educate the community of their potential risks. The non-invasive FibroScan® assessment is simple, painless, fast and free (now through the end of the year)!

ARE YOU ELIGIBLE?